Findings indicate that biomarkers related to immunomodulation may delay progression in Retinitis Pigmentosa.
These findings highlight that AH exosomal proteins hold promise as potential biomarkers and propose that immunomodulation and glial protection serve as conservative strategies to delay progression in cases of genetically unresolved RP.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: